Visterra Acquires Exclusive Patent License for Monoclonal Antibodies against ... Business Wire (press release) CAMBRIDGE, Mass.--(BUSINESS WIRE)--Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology ... Visterra acquires patent license from MIT for monoclonal antibodies against ... Visterra Acquires Antibody Family from MIT Visterra gets $8M to advance flu drug, acquires dengue drug |
